Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3619-3626

  Rossiter, Heidemarie ^a   Beissert, Stefan ^b   Mayer, Christoph ^a   Schön, Michael P ^c   Wienrich, B Gregor ^d   Tschachler, Erwin ^a,e   Kupper, Thomas S ^f  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e Centre de Recherches et d'Investigations Épidermiques et Sensorielles   (France)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYTOKERATIN 14; KERATIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS; SKIN TUMOR; TRANSGENIC MOUSE; ULTRAVIOLET B RADIATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, RAS; HUMANS; KERATINOCYTES; MICE; MICE, TRANSGENIC; MUTAGENESIS; PAPILLOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; ULTRAVIOLET RAYS;

EID: 0035328633     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Carcinogenesis in mouse and human cells: Parallels and paradoxes
2. The killer and the executioner: How apoptosis controls malignancy
3. Apoptosis in the treatment and pathogenesis of disease
4. Escaping cell death. Survival proteins in cancer
5. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
6. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
7. Alternative promoters and exons, somatic mutation and transcriptional deregulation of the bcl-2-Ig fusion gene in lymphoma
8. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
9. Expression of the apoptosis suppressing protein Bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification
10. Bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours, and in situ cancer
11. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated naso-pharyngeal carcinoma
12. Bcl-2 protein in non-small-cell lung carcinoma
13. Molecular mechanism of stomach carcinogenesis
14. Bcl-2 expression in human melanocytes and melanocytic tumors
15. Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture
16. Merkel cells and Merkel cell carcinoma express the bcl-2 proto-oncogene
17. Bcl-2 expression in epidermal keratinocyte diseases
18. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer
19. Peripheral T cell lymphoma in lckpr-bcl-2 transgenic mice
20. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation
21. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18)
22. Human keratin-I bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation
23. BCL-2 protein is topographically restricted to tissues characterized by apoptotic cell death
24. Abnormal bcl-2 and "tissue" transglutaminase expression in psoriatic skin
25. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal-cell carcinoma
26. Immunohistochemical expression of bcl-2 in melanomas and intradermal nevi
27. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions
28. UV irradiation induces downregulation of bcl-2 expression in vitro and in vivo
29. Over-expression of bcl-2 protects from UVB induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia
30. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice
31. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid
32. +K+-adenosine triphosphatase during mouse skin tumor progression
33. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice
34. Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation
35. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas
36. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II analysis and examples
37. Regulated expression of differentiation associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins
38. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
39. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation
40. Bcl-2 expression delays mammary tumor development in dimethylbenz(a) anthracenetreated transgenic mice
41. The anti-apoptosis function of bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
42. Diminished cell proliferation associated with the death-protective activity of bcl-2
43. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival
44. UV-B-induced apoptosis of keratinocytes: Evidence for partial involvement of tumor necrosis factor-α in the formation of sunburn cells
45. Nickel and skin irritants up-regulate tumor necrosis factor-α mRNA in keratinocytes by different but potentially synergistic mechanisms
46. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
47. The overexpression of bcl-2 inhibits UVA-mediated immediate apoptosis in Rat 6 fibroblasts: Evidence for involvement of bcl-2 as an antioxidant
48. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species
49. Low levels of reactive oxygen species as modulators of cell function
50. The cat and mouse games that genes, viruses, and cells play
51. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
52. Complementation by bcl-2 and C-Ha-ras oncogenes in malignant transformation of rat embryo fibroblasts
53. Apoptotic cell death induced by c-myc is inhibited by bcl-2
54. Cooperative interaction between c-myc and bcl-2 proto-oncogenes
55. Regulation of bcl.2 expression by oncogenic ras protein in hematopoietic cells
56. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and bcl-2
57. Mutated N-ras upregulates bcl-2 in human melanoma in vitro and in SCID mice
58. Correlation between bcl-2 over-expression and H-ras mutation in naturally occurring hepatocellular proliferative lesions of the B6C3F1 mouse
59. Genetic events and the role of TGF β in epithelial tumor progression
60. A bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas
61. Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis or infundibulum as well as the hair follicles
62. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter